Literature DB >> 3670619

Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study.

R Koike1, K Fujimori, T Yuasa, T Miyatake, I Inoue, T Saheki.   

Abstract

Two siblings with hyperornithinemia, hyperammonemia, and homocitrullinuria are reported. The clinical picture included protein intolerance, mental retardation, seizures, and stuporous episodes. One patient had cerebellar ataxia, myoclonus, convulsive seizure, and muscular weakness in both legs. Isolated liver mitochondria in the patient revealed that ornithine transport and citrulline synthesis were decreased, but urea cycle enzymes and ornithine aminotransferase were normal. Ornithine metabolism was decreased in cultured skin fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670619     DOI: 10.1212/wnl.37.11.1813

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

Review 1.  The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

Authors:  Diego Martinelli; Daria Diodato; Emanuela Ponzi; Magnus Monné; Sara Boenzi; Enrico Bertini; Giuseppe Fiermonte; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2015-03-11       Impact factor: 4.123

2.  Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia.

Authors:  Giorgia Olivieri; Stefano Pro; Daria Diodato; Matteo Di Capua; Daniela Longo; Diego Martinelli; Enrico Bertini; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2019-08-23       Impact factor: 4.123

3.  Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

Authors:  Yumi Hoshino; Minori Kodaira; Atsuhiro Matsuno; Tomoki Kaneko; Tetsuhiro Fukuyama; Kyoko Takano; Masahide Yazaki; Yoshiki Sekijima
Journal:  Intern Med       Date:  2021-08-24       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.